Won, Sung Min
Lee, Na Young
Oh, Ki-Kwang
Gupta, Haripriya
Sharma, Satya Priya
Kim, Kyung Hwan
Kim, Byoung Kook
Joung, Hyun Chae
Jeong, Jin Ju
Ganesan, Raja
Han, Sang Hak
Yoon, Sang Jun
Kim, Dong Joon
Suk, Ki Tae
Article History
Received: 4 August 2022
Revised: 18 November 2022
Accepted: 21 December 2022
First Online: 6 February 2023
Declarations
:
: The authors declare that there is no conflict of interest, including relevant financial interests, activities, relationships, affiliations, and any other conflict of interest as explicitly and implicitly expressed in the Editorial Policies for Authors.
: This study was controlled in accordance with ethical guidelines from the 1975 Helsinki Declaration as reflected by prior approval by the institutional review notice for human research in the hospital participating in the trial (2016-134). Basic information has been registered on ClinicalTrials.gov for registration in the public trial registry (NCT04339725). Informed consent for enrollment was received from each participant. This experiment was designed by selecting a candidate for the treatment of liver disease among the probiotics that approved by Ministry of Food and Drug Safety, Korean. All the procedures were licensed by the Institutional Animal Care and Use Committee of the College of Medicine, Hallym University R1(2019-04).